Orthofix Medical Inc (OFIX)
16.96
+0.77
(+4.76%)
USD |
NASDAQ |
Nov 01, 16:00
16.94
-0.02
(-0.09%)
After-Hours: 20:00
Orthofix Medical Enterprise Value: 739.08M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 739.08M |
| October 31, 2024 | 709.69M |
| October 30, 2024 | 715.80M |
| October 29, 2024 | 716.18M |
| October 28, 2024 | 709.31M |
| October 25, 2024 | 697.85M |
| October 24, 2024 | 694.42M |
| October 23, 2024 | 689.84M |
| October 22, 2024 | 703.58M |
| October 21, 2024 | 710.07M |
| October 18, 2024 | 704.34M |
| October 17, 2024 | 698.23M |
| October 16, 2024 | 703.20M |
| October 15, 2024 | 689.45M |
| October 14, 2024 | 706.25M |
| October 11, 2024 | 686.40M |
| October 10, 2024 | 664.26M |
| October 09, 2024 | 667.31M |
| October 08, 2024 | 668.08M |
| October 07, 2024 | 667.69M |
| October 04, 2024 | 675.33M |
| October 03, 2024 | 673.80M |
| October 02, 2024 | 685.26M |
| October 01, 2024 | 675.33M |
| September 30, 2024 | 687.93M |
| Date | Value |
|---|---|
| September 27, 2024 | 676.47M |
| September 26, 2024 | 678.77M |
| September 25, 2024 | 679.15M |
| September 24, 2024 | 687.55M |
| September 23, 2024 | 699.00M |
| September 20, 2024 | 710.45M |
| September 19, 2024 | 713.89M |
| September 18, 2024 | 707.78M |
| September 17, 2024 | 710.83M |
| September 16, 2024 | 722.67M |
| September 13, 2024 | 731.45M |
| September 12, 2024 | 740.99M |
| September 11, 2024 | 755.88M |
| September 10, 2024 | 715.41M |
| September 09, 2024 | 703.20M |
| September 06, 2024 | 711.60M |
| September 05, 2024 | 741.75M |
| September 04, 2024 | 725.34M |
| September 03, 2024 | 730.30M |
| August 30, 2024 | 757.41M |
| August 29, 2024 | 754.73M |
| August 28, 2024 | 750.15M |
| August 27, 2024 | 759.31M |
| August 26, 2024 | 752.82M |
| August 23, 2024 | 751.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
235.04M
Minimum
Oct 24 2022
840.08M
Maximum
Dec 24 2019
600.88M
Average
604.39M
Median
Mar 28 2024
Enterprise Value Benchmarks
| Stryker Corp | 150.76B |
| Globus Medical Inc | 10.08B |
| Perspective Therapeutics Inc | 524.04M |
| Xtant Medical Holdings Inc | 102.06M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.44M |
| Revenue (Quarterly) | 198.62M |
| Total Expenses (Quarterly) | 216.14M |
| EPS Diluted (Quarterly) | -0.88 |
| Gross Profit Margin (Quarterly) | 67.84% |
| Profit Margin (Quarterly) | -16.84% |
| Earnings Yield | -18.81% |
| Normalized Earnings Yield | -16.17 |